Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells

Molecular Endocrinology

Volumn 23, Issue 9, 2009, Pages 1415-1427

  Brighton, Paul J ^a   McDonald, John ^a   Taylor, Anthony H ^a   Challiss, R A John ^a   Lambert, David G ^a   Konje, Justin C ^a   Willets, Jonathon M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ADENYLATE CYCLASE; ANANDAMIDE; ARACHIDONYL 2 CHLOROETHYLAMIDE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; JTE 907; L 759656; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; RADIOLIGAND; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LIGAND BINDING; MYOMETRIUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ARACHIDONIC ACIDS; CELL LINE; CELL SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; MODELS, BIOLOGICAL; MUSCLE, SMOOTH; MYOMETRIUM; POLYMERASE CHAIN REACTION; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION;

EID: 69449089564     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0097     Document Type: Article

References (78)

1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI 1990 Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564 (Pubitemid 20238806)
2. Munro S, Thomas KL, Abu-Shaar M 1993 Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65 (Pubitemid 23305569)
3. Wengler T, Croix D, West M, Tramma G 1988 Marijuana and pregnancy. In: Dohler K, Pawlikowsky M, eds. Progress in neuropeptide research. Basel: Birkhauser Verlage Basel; 111-119
4. Hall W, Solowij N 1998 Adverse effects of cannabis. Lancet 352: 1611-1616
5. Tennes K 1984 Effects of marijuana on pregnancy and fetal development in the human. NIDA Res Monogr 44:115-123 (Pubitemid 15213537)
6. Greenland S, Richwald GA, Honda GD 1983 The effects of marijuana use during pregnancy. II. A study in a low-risk home-delivery population. Drug Alcohol Depend 11:359-366
7. Greenland S, Staisch KJ, Brown N, Gross SJ 1982 Effects of marijuana on human pregnancy, labor, and delivery. Neurobehav Toxicol Teratol 4:447-450
8. Fried PA, Watkinson B, Willan A 1984 Marijuana use during pregnancy and decreased length of gestation. Am J Obstet Gynecol 150:23-27 (Pubitemid 14074594)
9. Abel EL 1980 Prenatal exposure to cannabis: a critical review of effects on growth, development, and behavior. Behav Neural Biol 29:137-156 (Pubitemid 10020532)
10. Fried PA 1993 Prenatal exposure to tobacco and marijuana: effects during pregnancy, infancy, and early childhood. Clin Obstet Gynecol 36:319-337
11. Fried PA, Buckingham M, Von Kulmiz P 1983 Marijuana use during pregnancy and perinatal risk factors. Am J Obstet Gynecol 146:992-994
12. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R 1992 Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949 (Pubitemid 23026736)
13. Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R 2001 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA 98:3662-3665 (Pubitemid 32249827)
14. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Baywitch M, Barg J, Vogel Z 1995 Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90
15. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K 1995 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97
16. Pertwee RG 1999 Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6:635-664
17. Wang H, Xie H, Dey SK 2006 Endocannabinoid signaling directs periimplantation events. AAPS J 8:E425-E432 (Pubitemid 43958374)
18. Wenger T, Fragkakis G, Giannikou P, Probonas K, Yiannikakis N 1997 Effects of anandamide on gestation in pregnant rats. Life Sci 60:2361-2371 (Pubitemid 27235111)
19. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agrò A 2000 Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 355:1326-1329 (Pubitemid 30199005)
20. Habayeb OM, Taylor AH, Finney M, Evans MD, Konje JC 2008 Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. JAMA 299:1135-1136
21. Dennedy MC, Friel AM, Houlihan DD, Broderick VM, Smith T, Morrison JJ 2004 Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol 190:2-9; discussion, 3A
22. Wenger T, Fragkakis G, Giannikou P, Yiannikakis N 1997 The effects of prenatally administered endogenous cannabinoid on rat offspring. Pharmacol Biochem Behav 58:537-544 (Pubitemid 27394309)
23. El-Talatini MR, Taylor AH, Konje JC 5 February 2009 The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. Fertil Steril 10.1016/j.fertnstert. 2008.12.033
24. Habayeb OM, Taylor AH, Evans MD, Cooke MS, Taylor DJ, Bell SC, Konje JC 2004 Plasma levels of the endocannabinoid anandamide in women - a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab 89:5482-5487
25. Habayeb OM, Bell SC, Konje JC 2002 Endogenous cannabinoids: metabolism and their role in reproduction. Life Sci 70:1963-1977
26. Taylor AH, Ang C, Bell SC, Konje JC 2007 The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum Reprod Update 13:501-513 (Pubitemid 47299855)
27. Paria BC, Das SK, Dey SK 1995 The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc Natl Acad Sci USA 92:9460-9464
28. Park B, Gibbons HM, Mitchell MD, Glass M 2003 Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 24:990-995 (Pubitemid 37184768)
29. Pertwee RG 1997 Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129-180
30. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG 2002 International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202
31. Bouaboula M, Poinot-Chazel C, Bourrié B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P 1995 Activation of mitogen- activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637-641 (Pubitemid 26002235)
32. Rueda D, Galve-Roperh I, Haro A, Guzmán M 2000 The CB1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol 58:814-820 (Pubitemid 30761297)
33. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH 2001 MAP kinases. Chem Rev 101:2449-2476
34. Garrington TP, Johnson GL 1999 Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11:211-218 (Pubitemid 29164036)
35. Willets JM, Taylor AH, Shaw H, Konje JC, Challiss RA 2008 Selective regulation of H1 histamine receptor signaling by G protein- coupled receptor kinase 2 in uterine smooth muscle cells. Mol Endocrinol 22:1893-1907
36. Nong L, Newton C, Cheng Q, Friedman H, Roth MD, Klein TW 2002 Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers. J Neuroimmunol 127:169-176 (Pubitemid 34603588)
37. Showalter VM, Compton DR, Martin BR, Abood ME 1996 Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278:989-999
38. Pertwee RG 2005 Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 76:1307-1324
39. 50 of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
40. Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG 1999 Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 126:665-672 (Pubitemid 29087845)
41. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB 2000 The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129:227-230 (Pubitemid 30072640)
42. Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, Makriyannis A 1999 Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42:769-776 (Pubitemid 29110792)
43. Iwamura H, Suzuki H, Ueda Y, Kaya T, Inaba T 2001 In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J Pharmacol Exp Ther 296:420-425
44. Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, Murphy V, Pertwee RG, Campbell WB 1999 Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 289:1427-1433 (Pubitemid 29246674)
45. Schauwienold D, Plum C, Helbing T, Voigt P, Bobbert T, Hoffmann D, Paul M, Reusch HP 2003 ERK1/2-dependent contractile protein expression in vascular smooth muscle cells. Hypertension 41:546-552 (Pubitemid 36314630)
46. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR 1988 Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827-4833 (Pubitemid 18224442)
47. Perez-Reyes N, Halbert CL, Smith PP, Benditt EP, McDougall JK 1992 Immortalization of primary human smooth muscle cells. Proc Natl Acad Sci USA 89:1224-1228
48. Ball A, Wang JW, Wong S, Zielnik B, Mitchell J, Wang N, Stemerman MB, Mitchell BF 2006 Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism that does not involve activator protein-1. Am J Physiol Endocrinol Metab 291:E922-E928 (Pubitemid 44776742)
49. 2 receptor mediated activation of the mitogen activated protein kinase cascades in human uterine smooth muscle cells. Biochim Biophys Acta 1539:147-162
50. 2 production in human myometrial cells. J Soc Gynecol Invest 9:215-219
51. 2α receptor messenger RNA in human myometrial-derived ULTR cells requires the transcription factor, NFκB. Biol Reprod 75:697-704
52. Bouaboula M, Bourrié B, Rinaldi-Carmona M, Shire D, Le Fur G, Casellas P 1995 Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem 270:13973-13980
53. Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrié B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P 1996 Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 237:704-711 (Pubitemid 126443878)
54. Maneuf YP, Brotchie JM 1997 Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br J Pharmacol 120:1397-1398
55. Busch L, Sterin-Borda L, Borda E 2004 Expression and biological effects of CB1 cannabinoid receptor in rat parotid gland. Biochem Pharmacol 68:1767-1774 (Pubitemid 39278499)
56. Bonhaus DW, Chang LK, Kwan J, Martin GR 1998 Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. J Pharmacol Exp Ther 287:884-888 (Pubitemid 29131596)
57. Glass M, Felder CC 1997 Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17:5327-5333 (Pubitemid 27300300)
58. Calandra B, Portier M, Kernéis A, Delpech M, Carillon C, Le Fur G, Ferrara P, Shire D 1999 Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor. Eur J Pharmacol 374:445-455 (Pubitemid 29313457)
59. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED 1999 Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457 (Pubitemid 29361798)
60. i, initiates neurotransmitter release and promotes delayed cell death. J Neurochem 102:801-811
61. 2+ channel current. Am J Physiol 276:H2085-H2093
62. Högestätt ED, Zygmunt PM 2002 Cardiovascular pharmacology of anandamide. Prostaglandins Leukot Essent Fatty Acids 66:343-351
63. 9- tetrahydrocannabinol treatment. Mol Cell Neurosci 25:355-362
64. Werry TD, Sexton PM, Christopoulos A 2005 "Ins and outs" of seven-transmembrane receptor signalling to ERK. Trends Endocrinol Metab 16:26-33
65. Derkinderen P, Valjent E, Toutant M, Corvol JC, Enslen H, Ledent C, Trzaskos J, Caboche J, Girault JA 2003 Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci 23:2371-2382 (Pubitemid 36368926)
66. Galve-Roperh I, Rueda D,Gómez del Pulgar T, Velasco G,Guzmán M 2002 Mechanism of extracellular signal-regulated kinase activation by the CB1 cannabinoid receptor. Mol Pharmacol 62:1385-1392 (Pubitemid 35403833)
67. Friday BB, Adjei AA 2008 Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res 14:342-346
68. Grotenhermen F 2005 Cannabinoids. Curr Drug Targets CNS Neurol Disord 4:507-530
69. Hohmann AG, Suplita 2nd RL 2006 Endocannabinoid mechanisms of pain modulation. Aaps J 8:E693-708
70. Maccarrone M, Finazzi-Agró A 2003 The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ 10:946-955 (Pubitemid 37069472)
71. Melck D, Rueda D, Galve-Roperh I, De Petrocellis L, Guzmán M, Di Marzo V 1999 Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett 463:235-240 (Pubitemid 30001925)
72. Moghadam KK, Kessler CA, Schroeder JK, Buckley AR, Brar AK, Handwerger S 2005 Cannabinoid receptor I activation markedly inhibits human decidualization. Mol Cell Endocrinol 229:65-74 (Pubitemid 40018084)
73. Williams JP, Thompson JP, McDonald J, Barnes TA, Cote T, Rowbotham DJ, Lambert DG 2007 Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not μ, δ, or κ opioid receptors. Anesth Analg 105:998-1005 (Pubitemid 47479313)
74. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
75. Brown BL, Albano JD, Ekins RP, Sgherzi AM 1971 A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′- cyclic monophosphate. Biochem J 121:561-562
76. i and an irreversible ligandreceptor interaction. Mol Pharmacol 66:1544-1556
77. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
78. Thandi S, Blank JL, Challiss RA 2002 Group-I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal- regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways. J Neurochem 83:1139-1153 (Pubitemid 35397124)